AIF1 and Alzheimer disease: Indeed, notwithstanding the well-documented activation of microglia in AD [15], a recent systematic review of microglial markers in post-mortem human AD tissue reported that half of the publications quantifying Iba1 levels detected no change in expression compared to controls.